Bristol Myers Squibb Reblozyl gets expanded European nod for anemia in lower risk Myelodysplastic Syndromes Ruchika Sharma4 April 2024 2:13 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has expanded approval of Reblozyl (luspatercept) to include...
Bristol Myers Squibb gets EMA Committee positive opinion for Reblozyl for adults with Transfusion-Dependent Anemia due to Low-to Intermediate-Risk Myelodysplastic Syndromes Ruchika Sharma25 Feb 2024 3:30 PM ISTPrinceton: Bristol Myers Squibb has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Imetelstat Reduce Red Blood Cell Transfusions in Lower-Risk Myelodysplastic Syndromes Jacinthlyn Sylvia22 Jan 2024 9:30 AM ISTImetelstat presents a unique mode of action, providing long-lasting transfusion independence (around 1 year) and exhibiting disease-modifying effects...
Imetelstat reduces RBC transfusion dependence in patients with lower-risk myelodysplastic syndromes Medha Baranwal12 Dec 2023 1:00 AM ISTUSA: An investigational, first-in-class telomerase inhibitor was shown to improve rates of red blood cell (RBC) transfusion independence in patients...
Bristol Myers Squibb gets USFDA nod for Reblozyl as first line treatment of Anemia in lower risk MDS Ruchika Sharma29 Aug 2023 11:09 AM ISTReblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.
Gilead to discontinue Phase 3 ENHANCE study of Magrolimab plus Azacitidine in higher-risk MDS Ruchika Sharma24 July 2023 4:45 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes (MDS) has been...
Vitamin B5 could improve outcomes in patients with a rare type of blood cancer: Study Dr. Kamal Kant Kohli4 March 2023 10:15 AM ISTUK: Vitamin B5, in combination with existing drugs, could improve outcomes in patients with Myelodysplastic syndromes (MDS), a rare type of blood...
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Cipla Cancer drug Lenalidomide bags USFDA okay Ruchika Sharma7 Sept 2022 4:22 PM ISTMumbai: Drugmaker, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Zydus Cadila cancer drug Lenalidomide gets USFDA okay Ruchika Sharma17 Aug 2021 4:32 PM ISTAhmedabad: Drugmaker, Zydus Cadila, today announced that the company has received tentative approval from the United States Food & Drug...
